Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
HK Stock MarketDetailed Quotes
00460 SIHUAN PHARM
- 0.720
- -0.010-1.37%
Market Closed Apr 30 16:08 CST
6.66BMarket Cap-28.80P/E (TTM)
0.760High0.710Low54.50MVolume0.740Open0.730Pre Close39.99MTurnover0.59%Turnover RatioLossP/E (Static)9.25BShares1.02052wk High1.41P/B6.66BFloat Cap0.47452wk Low0.02Dividend TTM9.25BShs Float6.005Historical High0.021Dividend LFY6.85%Amplitude0.301Historical Low0.733Avg Price1000Lot Size2.92%Div YieldTTM2.92%Div Yield LFY
SIHUAN PHARM Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -165.59%-428.29M | 41.88%-19.21M | 92.27%-161.26M | -158.98%-33.05M | -529.24%-2.09B | -93.16%56.04M | -33.50%486.05M | 195.11%819.48M | 129.63%730.93M | 116.08%277.68M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -18.69%-175.55M | -41.76%-77.58M | -0.76%-147.91M | -10.96%-54.73M | -13.88%-146.79M | -64.15%-49.32M | -130.11%-128.9M | -16.92%-30.05M | 57.91%-56.02M | 51.60%-25.7M |
| Interest expense - adjustment | 2.08%274.93M | -0.81%132.46M | 27.54%269.34M | 34.35%133.54M | 77.00%211.18M | 529.99%99.4M | 6,918.29%119.31M | 1,324.01%15.78M | -30.89%1.7M | -29.02%1.11M |
| Investment loss (gain) | -71.60%15.23M | -109.07%-4.14M | -33.70%53.62M | -4.32%45.67M | -49.00%80.88M | -5.85%47.73M | 859.70%158.58M | 308.17%50.7M | 129.82%16.52M | 75.12%12.42M |
| Impairment and provisions: | 358.40%15.89M | 194.32%7.47M | -99.81%3.47M | -105.22%-7.92M | 944.00%1.85B | --151.57M | --176.85M | ---- | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | --1.13B | --98.1M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | -16.45%9.54M | -8.58%1.96M | -87.42%11.42M | -80.02%2.14M | 903.40%90.78M | --10.73M | --9.05M | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | 179.81%6.35M | 154.74%5.51M | -127.96%-7.95M | -123.54%-10.06M | -22.09%28.44M | --42.75M | --36.51M | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | --8.76M | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | 347.05%586.96M | ---- | --131.3M | ---- | ---- | ---- |
| Revaluation surplus: | 116.01%21.09M | -286.33%-5.17M | -1,241.02%-131.77M | -106.27%-1.34M | 985.58%11.55M | 412.43%21.34M | 51.40%-1.3M | -259.85%-6.83M | -114.43%-2.68M | -108.64%-1.9M |
| -Other fair value changes | 116.01%21.09M | -286.33%-5.17M | -1,241.02%-131.77M | -106.27%-1.34M | 985.58%11.55M | 412.43%21.34M | 51.40%-1.3M | -259.85%-6.83M | -114.43%-2.68M | -108.64%-1.9M |
| Asset sale loss (gain): | -86.61%-53.42M | -329.66%-3.52M | 91.10%-28.63M | 100.73%1.53M | -402.82%-321.57M | -7,740.12%-209.65M | 53.56%-63.95M | 1,155.38%2.74M | -2,141.78%-137.72M | -111.35%-260K |
| -Loss (gain) from sale of subsidiary company | -132.92%-48.2M | ---- | 91.23%-20.69M | 100.26%558K | -255.45%-235.89M | ---211.59M | 56.57%-66.36M | ---- | ---152.8M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 71.04%-1.27M | -93.60%59K | -264.40%-4.38M | 14.11%922K | 10.45%2.66M | -68.06%808K | 24.54%2.41M | 2,138.94%2.53M | -71.30%1.94M | -95.07%113K |
| -Loss (gain) from selling other assets | -11.25%-3.96M | -6,733.33%-3.58M | 95.97%-3.56M | -95.26%54K | ---88.34M | 432.24%1.14M | ---- | 157.37%214K | --13.14M | ---373K |
| Depreciation and amortization: | 14.23%258.43M | 0.77%123.27M | -38.82%226.23M | -31.67%122.33M | 19.54%369.81M | 17.06%179.02M | 11.17%309.37M | 7.85%152.93M | -21.54%278.28M | -18.59%141.8M |
| -Amortization of intangible assets | 76.64%35.93M | 157.56%17.33M | -44.90%20.34M | -58.20%6.73M | 15.73%36.91M | 1.30%16.1M | 10.97%31.9M | 19.28%15.89M | -70.37%28.74M | -72.44%13.32M |
| Special items | 369.24%418.02M | -50.27%25.77M | -4.25%89.08M | 5.05%51.81M | 56.75%93.03M | 217.27%49.32M | 191.70%59.35M | -28,711.56%-42.06M | 5,663.74%20.35M | -16.48%147K |
| Operating profit before the change of operating capital | 101.14%346.33M | -30.45%179.34M | 196.47%172.18M | -25.36%257.85M | -94.79%58.08M | -64.12%345.46M | 31.01%1.12B | 137.53%962.7M | -51.67%851.36M | -68.12%405.3M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 246.53%130.78M | 829.72%79.96M | 162.44%37.74M | -382.03%-10.96M | 73.35%-60.44M | 105.56%3.89M | -247.21%-226.81M | -155.74%-69.82M | 39.78%-65.32M | 57.33%-27.3M |
| Accounts receivable (increase)decrease | -201.04%-268.55M | -2,868.88%-141.1M | 262.39%265.79M | 101.50%5.1M | 33.26%-163.68M | 5.26%-340.27M | 9.01%-245.24M | -1,409.01%-359.17M | -214.64%-269.52M | -62.94%27.44M |
| Accounts payable increase (decrease) | 98.11%-3.77M | 60.29%-66.9M | -147.84%-198.81M | -134.96%-168.48M | 112.28%415.54M | 198.00%481.98M | 202.26%195.75M | 170.17%161.74M | 65.37%64.76M | -165.81%-230.49M |
| Special items for working capital changes | 1,905.84%128.01M | 191.75%35.45M | 113.87%6.38M | 56.10%-38.63M | -254.63%-46.03M | ---88M | 121.27%29.77M | ---- | ---139.94M | ---- |
| Cash from business operations | 17.48%332.81M | 93.29%86.74M | 39.22%283.28M | -88.87%44.88M | -76.58%203.47M | -42.04%403.06M | 96.86%868.83M | 297.52%695.45M | -77.10%441.34M | -89.28%174.95M |
| Other taxs | -6.11%-88.92M | -203.66%-50.28M | 46.62%-83.8M | 41.29%-16.56M | 22.87%-156.98M | 64.91%-28.2M | 4.99%-203.53M | 45.65%-80.36M | 57.95%-214.21M | 61.75%-147.85M |
| Net cash from operations | 22.26%243.89M | 28.75%36.46M | 329.07%199.49M | -92.45%28.32M | -93.01%46.49M | -39.06%374.86M | 192.91%665.29M | 2,170.29%615.09M | -83.98%227.13M | -97.82%27.09M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -7.85%147.62M | 74.51%74.93M | 7.67%160.2M | 36.48%42.94M | 11.33%148.79M | -19.50%31.46M | 144.08%133.64M | 69.88%39.08M | -66.57%54.76M | -59.51%23.01M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | --317.64M | ---- | ---- | ---- |
| Loan receivable (increase) decrease | 655.40%195.41M | 1,079.51%119.5M | 64.77%-35.18M | 77.53%-12.2M | -348.85%-99.86M | 19.44%-54.3M | 63.56%-22.25M | -103.48%-67.4M | 11.66%-61.04M | 3.57%-33.12M |
| Decrease in deposits (increase) | -53.56%-100.67M | 486.18%136M | -101.27%-65.56M | 195.84%23.2M | -39,140.96%-32.57M | ---24.21M | 99.94%-83K | ---- | ---144.55M | ---- |
| Sale of fixed assets | -76.10%3.71M | -32.97%1.34M | 8.26%15.54M | -84.21%2M | 358.12%14.35M | 2,748.54%12.68M | -43.16%3.13M | -78.13%445K | 154.83%5.51M | 152.80%2.04M |
| Purchase of fixed assets | 43.59%-70.71M | 34.48%-48.34M | 68.85%-125.35M | 72.12%-73.78M | 33.04%-402.46M | 17.30%-264.67M | -18.63%-601.02M | -46.13%-320.03M | -1.17%-506.64M | -64.12%-219M |
| Selling intangible assets | 18,244.44%6.6M | ---- | -99.10%36K | ---- | --3.98M | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 31.99%-115.67M | 28.13%-57.06M | 11.18%-170.07M | 3.03%-79.39M | -53.72%-191.48M | -282.17%-81.87M | -68.39%-124.57M | 71.36%-21.42M | 17.01%-73.98M | -63.15%-74.8M |
| Sale of subsidiaries | 134.51%35M | ---- | -83.13%14.93M | -91.56%9.22M | --88.45M | --109.29M | ---- | ---- | --117.57M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | -10,270.89%-153.38M | -1,517.14%-106.3M | --1.51M | --7.5M |
| Recovery of cash from investments | -8.95%9.53B | 269.35%3.94B | -32.25%10.47B | -87.42%1.07B | -23.48%15.45B | -9.00%8.48B | 8.60%20.19B | 43.20%9.32B | -9.85%18.59B | -30.11%6.51B |
| Cash on investment | 12.07%-8.87B | -345.53%-3.91B | 39.35%-10.09B | 89.88%-877.98M | 17.14%-16.64B | 10.86%-8.68B | -6.20%-20.08B | -41.51%-9.74B | 3.41%-18.91B | 20.09%-6.88B |
| Net cash from investment operations | 346.34%758.24M | 152.35%253.26M | 110.23%169.88M | 121.24%100.36M | -392.08%-1.66B | 47.24%-472.43M | 63.50%-337.57M | -33.82%-895.36M | -267.54%-924.78M | -223.52%-669.1M |
| Net cash before financing | 171.31%1B | 125.15%289.72M | 122.88%369.36M | 231.89%128.68M | -592.68%-1.61B | 65.19%-97.57M | 146.98%327.72M | 56.35%-280.26M | -135.42%-697.65M | -135.93%-642.01M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -9.10%350.5M | -13.71%280.46M | -19.72%385.59M | 74.34%325.02M | -42.55%480.32M | -62.85%186.42M | -24.21%836.08M | -14.64%501.77M | 5,706.20%1.1B | --587.82M |
| Refund | -60.27%-641.89M | -58.44%-294.82M | -26.98%-400.51M | -443.16%-186.07M | 41.85%-315.43M | 91.70%-34.26M | -44.24%-542.44M | ---412.94M | -250.49%-376.08M | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | --2.74M | ---- | ---- | ---- |
| Interest paid - financing | 19.48%-43.46M | 14.08%-23.4M | 3.05%-53.98M | -8.02%-27.23M | -99.33%-55.68M | -69.83%-25.21M | -9,911.47%-27.93M | -5,018.62%-14.84M | 33.89%-279K | -13.73%-290K |
| Dividends paid - financing | 42.22%-179.43M | 99.47%-1.6M | 76.39%-310.56M | 69.77%-304.56M | -569.86%-1.32B | -1,270.94%-1.01B | 86.40%-196.39M | -200.00%-73.5M | -626.52%-1.44B | 84.78%-24.5M |
| Absorb investment income | 229.20%33.49M | -99.04%86K | -98.96%10.17M | -97.77%8.94M | 24.33%980M | 79.18%400M | -13.88%788.22M | 2,029,390.91%223.24M | --915.22M | -99.99%11K |
| Issuance expenses and redemption of securities expenses | 39.97%-20.3M | 58.92%-13.89M | ---33.81M | ---33.81M | ---- | ---- | ---206.41M | ---29.17M | ---- | ---- |
| Other items of the financing business | ---749.22M | ---- | ---- | ---- | ---- | ---- | 1,099.80%99.98M | --113.41M | -107.57%-10M | ---- |
| Net cash from financing operations | -199.93%-1.26B | 73.91%-58.32M | -75.60%-419.56M | 54.31%-223.51M | -131.83%-238.93M | -259.31%-489.21M | 306.76%750.66M | -45.30%307.07M | 210.16%184.54M | 440.33%561.37M |
| Net Cash | -410.55%-256.28M | 344.01%231.4M | 97.29%-50.2M | 83.84%-94.83M | -271.88%-1.85B | -2,288.74%-586.78M | 310.17%1.08B | 133.25%26.81M | -128.47%-513.1M | -104.97%-80.63M |
| Begining period cash | -1.31%3.78B | -1.31%3.78B | -32.62%3.83B | -32.62%3.83B | 23.42%5.68B | 23.42%5.68B | -10.03%4.6B | -10.03%4.6B | 54.37%5.12B | 54.37%5.12B |
| Cash at the end | -6.78%3.52B | 7.39%4.01B | -1.31%3.78B | -26.72%3.73B | -32.62%3.83B | 10.04%5.1B | 23.42%5.68B | -8.05%4.63B | -10.03%4.6B | 2.03%5.04B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | --3.14B | ---- | ---- | -45.26%2.71B | ---- | 0.23%4.95B |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | --3.14B | ---- | ---- | -45.26%2.71B | ---- | 0.23%4.95B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts